A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Zavegepant Intranasal (IN) for the Acute Treatment of Migraine in Asian Adults

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Zavegepant Intranasal (IN) for the Acute Treatment of Migraine in Asian Adults soansm01 Thu, 05/14/2026 - 08:57 Zavegepant Zavegepant PHASE III Wed, 11/29/2023 - 12:00 Fri, 05/30/2025 - 12:00 NCT05989048 C5301008 Public Disclosure Synopsis.pdf (231.45 KB) N https://clinicaltrials.gov/study/NCT05989048?term=C5301008&viewType=Card&rank=1 C5301008